BRIEF-Novartis says data reinforces Cosentyx effectiveness By: Reuters: Company News January 16, 2018 at 01:19 AM EST * NOVARTIS NEW DATA REINFORCES SUPERIORITY OF COSENTYX® VERSUS STELARA®* IN ACHIEVING SKIN CLEARANCE FOR PSORIASIS PATIENTS Read More >> Related Stocks: Johnson & Johnson Novan Inc